Historically, the medical devices world has been a highly proprietary industry, having long been characterized by the development of specialized, patented technologies that are closely guarded by ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA has cleared a next-generation integrated ...

Abbott Diabetes Care shared some real-world evidence this morning at the International Conference on Advanced Technologies & Treatments for Diabetes, bolstering clinical trial data about the ...

Abbott Diabetes Care is recalling certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to falsely low glucose readings.

Traditional food logging apps offer feedback after the fact—Libre Assist 1 offers help in-the-moment to inform mealtime decisions before every bite Libre Assist 1 leverages AI to predict how food ...

A newly issued alert links certain FreeStyle Libre 3 and 3 Plus glucose-monitoring sensors to at least seven deaths and hundreds of serious injuries. The problem stems from sensors giving falsely low ...

FreeStyle Libre is a continuous glucose monitoring (CGM) system. It uses a sensor to read and check a person’s glucose levels. People with diabetes can use FreeStyle Libre to help manage the condition ...

As diabetes device makers race to build completely hands-off artificial pancreas systems, Abbott’s continuous glucose monitors are getting a significant upgrade. New regulatory clearance passed down ...

Abbott is honing its financial projections for the remainder of this year, nudging their average slightly higher as it reports continued growth among its core business areas—bookended by big gains in ...

ABBOTT PARK, Ill., Jan. 5, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), a leading healthcare company, today unveiled Libre Assist,1 a groundbreaking feature within the Libre app5 designed to help the ...